Tower Research Capital LLC (Trc) Abeona Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,989 shares of ABEO stock, worth $34,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,989
Previous 37,977
84.23%
Holding current value
$34,137
Previous $161,000
77.02%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ABEO
# of Institutions
61Shares Held
26.9MCall Options Held
614KPut Options Held
45K-
Suvretta Capital Management, LLC New York, NY3.69MShares$21 Million0.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.43MShares$19.6 Million1.29% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$18.5 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.3MShares$13.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$11.4 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $33.9M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...